Susan O’Brien, MD from the University of California, Irvine, CA discusses Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and the…
Browsing: Acute Lymphoblastic Leukemia
Rafael Fonseca, MD from the Mayo Clinic, Scottsdale, AZ discusses the importance of monoclonal antibodies for multiple myeloma (MM). At…
Press brief by Katherine A High, MD of the The Children’s Hospital of Philadelphia, at the 2016 Annual Meeting of…
Press brief by Johan Richter, MD, PhD of the SkÃ¥ne University Hospital Lund, Lund, Sweden, at the 2016 Annual Meeting…
Philippe Rousselot, MD, PhD from Versailles Hospital and University, Versailles, France discusses the concern of molecular relapse in chronic myeloid…
Emili Montserrat, MD, PhD from the University of Barcelona, Barcelona, Spain discusses the goals and work of the European Research…
Georg Lenz, MD, PhD, from the University of Münster, Münster, Germany discusses the clinical significance of diagnosing diffuse large B-cell…
Katja Weisel, MD from University Hospital Tuebingen, Tuebingen, Germany gives an overview of the current situation for multiple myeloma patients…
Philippe Rousselot, MD, PhD from Versailles Hospital and University, Versailles, France, discusses the use of blinatumomab in patients with acute…
Stephan Grupp, MD, PhD from Children’s Hospital of Philadelphia, Philadelphia, PA discusses his research into pediatric acute lymphoid leukemia (ALL).…
Michael Hallek, MD from the University of Cologne, Cologne, Germany discusses the potential benefits of biosimilars. Prof. Hallek suggests that…
Philippe Rousselot, MD, PhD from Versailles Hospital and University, Versailles, France, discusses the role of inotuzumab ozogamicin, which is currently…
Emili Montserrat, MD, PhD from the University of Barcelona, Barcelona, Spain discusses the best treatment advice for patients with chronic…
Emili Montserrat, MD, PhD from the University of Barcelona, Barcelona, Spain discusses the issue of drug cost in chronic lymphocytic…
Emili Montserrat, MD, PhD from the University of Barcelona, Barcelona, Spain discusses the influence of the European Research Initiative on…
For decades, the hallmark of medical treatment for cancer and hematological malignancies has been intravenous cytotoxic chemotherapy. These drugs target…
Stephan Grupp, MD, PhD from Children’s Hospital of Philadelphia, Philadelphia, PA outlines his work at the University of Pennsylvania. Currently…
The National Cancer Act signed in 1971 officially started what is commonly referred to as the war against cancer. Since…
Peter Hillmen, MBChb, PhD, FRCP, FRCPath from St. James’ University Hospital, Leeds, UK discusses the use of the word ‘cure’…
Peter Hillmen, MBChb, PhD, FRCP, FRCPath from St. James’ University Hospital, Leeds, UK discusses allogeneic stem cell transplantation for chronic…
Michele Baccarani, MD from University of Bologna, Bologna, Italy, discusses the symposium on Current and emerging treatment goals in chronic…
Georg Lenz from the University of Münster, Münster, Germany discusses the current unmet need in diffuse large B-cell lymphoma (DLBCL),…
Georg Lenz from the University of Münster, Münster, Germany discusses diffuse large B-cell lymphoma (DLBCL) at the European Hematology Association…
Haifa Kathrin Al-Ali, MD from the University of Leipzig, Leipzig, Germany discusses what can be done for myelofibrosis patients who…
Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD from Oxford University Hospitals NHS Foundation Trust, Oxford, UK discusses the next steps that…
Gail Roboz, MD from Weill Medical College of Cornell University, New York, NY discusses the standardization of flow cytometry in…
Giuseppe Saglio, MD of the University of Turin, Turin, Italy discusses the pros and cons of chronic myeloid leukemia (CML)…
Mark Caulfield, MD from the Genomics England and Queen Mary University, London, UK discusses aspects on the UK hematology community.…
Peter Hillmen, MBChb, PhD, FRCP, FRCPath from St. James’ University Hospital, Leeds, UK talks about current clinical trials in chronic…
Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD from Oxford University Hospitals NHS Foundation Trust, Oxford, UK discusses the different forms of multiple…
Dr. James Pellicane discusses the advantages of using the BioZorb implant during breast cancer surgery. By clearly identifying the surgical…
Dr. Stephen Harms, a breast imaging expert at Medical Associates of Northwest Arkansas, reports that the BioZorb device is easily…
Dr. Jennifer Gass, Chief of Surgery at Women & Infants Hospital of Rhode Island, describes how the 3D BioZorb device…
The BioZorb marker is valuable in oncoplastic breast reduction procedures during breast cancer surgery, according to MedStar Georgetown University Hospital…
V. Suzane Klimberg, MD, FACS, explains how the BioZorb implant satisfies an unmet need for breast surgeons and patients by…
Jason A. Zell, DO, MPH Associate Professor, Depts. Of Medicine & Epidemiology School of Medicine University of California, Irvine discusses…
Ignatius Ou, MD PhD UC Irvine School of Medicine discusses recently released data from ASCO 2016 about lung cancer
Chaitali Nangia, MD of UC Irvine Health presents Breast Cancer updates 2016 which includes data recently released from ASCO 2016
Samuel J. Klempner, MD Director of Precision Medicine The Angeles Clinic and Research Institute goes over the new data from…
Kanwar Kahlon, MD Assistant Clinical Professor, Department of Medicine UC Irvine discusses ASCO 2016 data concerning the treatment of Multiple…
John Fruehauf, MD, phd Director Clinical pharmacology and developmental therapeutics UCI Irvine Comprehensive cancer center goes over the best data…
Dr. Eddie Mendez discusses novel treatments in head and neck cancers at Seattle Cancer Care Alliance, particularly in immunotherapy, robotic…
The state-of-the-art MRgRT suite at the Princess Margaret Cancer Centre combines the best of medical imaging with radiation therapy to…
How can patients best manage side effects for better quality of life? Andrew Schorr, facilitates a dialogue between advanced prostate…
AACR brought young investigators to Capitol Hill to explain the importance for continued momentum for ample funding for cancer support.…
Owen O’Connor, MD, PhD from Columbia University Medical Center, New York, NY discusses the positive trend in the research for…
Michael Hallek, MD from the University of Cologne, Cologne, Germany gives an overview of the German CLL Study Group (GCLLSG),…
Michael Hallek, MD from the University of Cologne, Cologne, Germany talks about the issue of drug cost in oncology. According…
Davide Rossi, MD, PhD from University of Eastern Piedmont, Vercelli, Italy discusses the unmet needs of chronic lymphocytic leukemia (CLL)…